Ligand validation:8IRC

HTG: heptyl 1-thio-beta-D-glucopyranoside

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8IRC_HTG_B_626	70%	40%	0.114	0.932	1.03	1.35	2	4	0	0	100%	1
8IRC_HTG_b_625	66%	36%	0.113	0.917	1	1.59	2	3	0	0	100%	1
8IRC_HTG_B_622	29%	34%	0.181	0.836	1.02	1.7	2	6	0	0	100%	1
8IRC_HTG_b_622	24%	27%	0.19	0.818	1.15	1.91	2	7	0	0	100%	1
8IRC_HTG_B_623	20%	46%	0.263	0.864	0.78	1.33	1	1	0	0	100%	1
8IRC_HTG_c_522	13%	37%	0.285	0.83	0.93	1.63	2	2	0	0	100%	1
8IRC_HTG_C_522	6%	41%	0.372	0.802	0.89	1.46	1	2	0	0	100%	1
8IRC_HTG_d_411	5%	38%	0.326	0.75	0.99	1.5	1	1	0	0	84%	0.8421
8IRC_HTG_V_203	4%	62%	0.449	0.892	0.28	1.13	-	1	0	0	58%	0.5789
8IRC_HTG_D_414	3%	39%	0.316	0.694	1.04	1.4	2	1	0	0	84%	0.8421
8IRC_HTG_b_623	1%	31%	0.534	0.625	1.04	1.8	1	2	0	0	100%	1
5V2C_HTG_O_303	94%	35%	0.072	0.972	1.58	1.07	2	2	0	0	100%	1
3WU2_HTG_O_303	89%	38%	0.092	0.971	1.17	1.32	2	1	0	0	100%	1
8IR7_HTG_b_625	81%	38%	0.086	0.939	0.97	1.5	2	3	0	0	100%	1
8IR6_HTG_b_625	81%	37%	0.088	0.941	1.07	1.48	2	4	0	0	100%	1
8IRA_HTG_B_625	81%	46%	0.097	0.95	0.97	1.12	2	2	0	0	100%	1
8IR9_HTG_B_623	81%	46%	0.098	0.95	0.99	1.13	2	3	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.